autoinflammatory - Biweekly newsletter of the International Cytokine & Interferon Society

BMS Session at Cytokines 2024 / KAI 2024 Joint Meeting – Inflammasome-activated cytokines in human diseases

September 16, 2024

BMS Session at Cytokines 2024 / KAI 2024 Joint Meeting – Inflammasome-activated cytokines in human diseases
Scott W. Canna, MD [READ MORE]

Member Highlight: Meet Kristin Patrick, Ph.D.

April 14, 2025

As an RNA biologist-turned-immunologist, my lab studies the role of RNA processing in macrophage activation and antibacterial immunity. My lab is a vibrant, supportive and collaborative space that values diversity, creativity, and hard work. My name is Kristin Patrick, Ph.D. I am currently an Associate Professor in the Department of [READ MORE]

“Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection” published in the Journal of Experimental Medicine

April 14, 2025

The following interview was conducted by Signals+ Editor Di Yu, Ph.D. The Journal of Experimental Medicine (JEM) recently published the study by Benjamin J. Broomfield et. al. showing early, short-term inhibition of IFN-I optimizes TSCM cell differentiation. Broomfield is a Ph.D. candidate in the Joanna Groom lab at WEHI. Highlights of [READ MORE]

Joaquin Espinosa enjoying a hike in the woods

Member Highlight: Meet Joaquin M. Espinosa, Ph.D.

March 31, 2025

My team investigates the impacts of interferon hyperactivity and immune dysregulation in Down syndrome. We are testing the hypothesis that immune dysregulation drives many of the clinical and developmental hallmarks of Down syndrome. There is now a vibrant community of immunologists studying Down syndrome, and I believe that attending the [READ MORE]

New Member Mini-Bios

New Member Mini-Bio: Chen Yao, Ph.D., University of Texas Southwestern Medical Center

March 31, 2025

Dr. Chen Yao is an assistant professor in the Department of Immunology at UT Southwestern Medical Center. Having earned her Ph.D. from the University of Minnesota under the guidance of Dr. Daniel Kaplan, Dr. Yao furthered her expertise through postdoctoral training in the systems immunology laboratory led by Dr. John [READ MORE]

Early Interferon-beta Treatment for West-Nile Virus Infection

March 31, 2025

ClinicalTrials.gov ID NCT06510426 Sponsor Tel-Aviv Sourasky Medical Center Study Overview – Brief Summary West Nile virus (WNV) is a mosquito-borne virus which in majority of cases causes only self-limited disease. Despite that, in minority of cases (~0.5%) it can infect the brain and cause severe and even life-threatening disease (neuroinvasive disease). [READ MORE]

Share this: